Aurinia Pharmaceuticals Langfristige Verbindlichkeiten 2011-2025 | AUPH

Langfristige Verbindlichkeiten Jährlich Aurinia Pharmaceuticals

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	-	41.9 M	26 M	16 M	13.1 M	9.99 M	4.44 M	3.8 M	2.61 M	5.78 M

Alle Zahlen in USD-Währung

Indikatorenreichweite aus Jahresberichten

Höchstwert	Mindestwert	Durchschnitt
41.9 M	2.61 M	13.7 M

Langfristige Verbindlichkeiten anderer Aktien in der Pharmaeinzelhändler

Name	Langfristige Verbindlichkeiten	Preis	% 24h	Marktkapitalisierung	Land
MorphoSys AG MOR	40.2 M	-	2.43 %	$ 254 M	Germany
Aclaris Therapeutics ACRS	5.95 M	$ 3.03	-	$ 234 M	USA
Aptevo Therapeutics APVO	5 M	$ 0.61	-	$ 168 K	USA
Autolus Therapeutics plc AUTL	50.6 M	$ 1.67	-	$ 426 M	Britain
Alterity Therapeutics Limited ATHE	73.6 K	$ 3.12	0.81 %	$ 7.51 B	Australia
Alpine Immune Sciences ALPN	15.9 M	-	-	$ 2.17 B	USA
Midatech Pharma plc MTP	110 K	-	-18.52 %	$ 27.3 M	Britain
Alexion Pharmaceuticals, Inc. ALXN	4.83 B	-	-	$ 40.3 B	USA
Biophytis SA BPTS	2.02 M	-	-13.47 %	$ 169 M	France
Aptorum Group Limited APM	2.21 M	$ 1.14	-	$ 6.22 M	China
BioVie BIVI	62.5 K	$ 1.21	-	$ 1.79 M	USA
Aeglea BioTherapeutics AGLE	4.74 M	-	-	$ 1.01 B	USA
AIkido Pharma AIKI	2.29 M	-	1.93 %	$ 17.4 M	USA
EyeGate Pharmaceuticals, Inc. EYEG	6.39 M	-	-1.52 %	$ 24.7 M	USA
AlloVir ALVR	5.46 M	-	4.14 %	$ 49.1 M	USA
Ascendis Pharma A/S ASND	101 M	$ 208.98	-	$ 5 B	Danmark
Ampio Pharmaceuticals AMPE	3.53 M	-	-11.43 %	$ 502 K	USA
Applied Molecular Transport AMTI	106 M	-	-	$ 10.1 M	USA
Avenue Therapeutics ATXI	2.03 M	-	-52.27 %	$ 4.45 M	USA
AVROBIO AVRO	276 K	-	1083.1 %	$ 745 M	USA
BioDelivery Sciences International BDSI	78.7 M	-	-4.8 %	$ 255 M	USA
Athersys ATHX	5.4 M	-	3.77 %	$ 22.4 M	USA
Институт стволовых клеток человека ISKJ	541 M	-	-	-	Russia
ARCA biopharma ABIO	409 K	-	1052.0 %	$ 415 M	USA
Can-Fite BioPharma Ltd. CANF	1.63 M	$ 0.21	-	$ 457 M	Israel
Bellicum Pharmaceuticals BLCM	48 M	-	-9.72 %	$ 5.89 M	USA
Acasti Pharma ACST	12.2 M	-	4.01 %	$ 150 M	Canada
Adaptimmune Therapeutics plc ADAP	23.6 M	-	-15.15 %	$ 60.3 M	Britain
Catalyst Biosciences CBIO	981 K	$ 12.35	-0.16 %	$ 813 M	USA
Berkeley Lights BLI	22.3 M	-	-7.31 %	$ 87 M	USA
Albireo Pharma ALBO	79.1 M	-	-0.23 %	$ 916 M	USA
Certara CERT	482 M	$ 8.89	-	$ 1.43 B	USA
BioNTech SE BNTX	341 M	$ 94.52	-	$ 27.2 B	Germany
Amphastar Pharmaceuticals AMPH	69.4 M	$ 27.12	-	$ 1.31 B	USA
BeiGene, Ltd. BGNE	374 M	-	0.49 %	$ 251 B	Cayman-islands
Calithera Biosciences CALA	4.82 M	-	-10.95 %	$ 876 K	USA
Anika Therapeutics ANIK	26.1 M	$ 9.55	-	$ 140 M	USA
bluebird bio BLUE	219 M	-	-	$ 546 M	USA
Arena Pharmaceuticals ARNA	52.2 M	-	-6.81 %	$ 3.04 B	USA
Acer Therapeutics ACER	244 K	-	2.71 %	$ 14 M	USA
Axon Enterprise AXON	107 M	$ 583.84	-	$ 44.2 B	USA
Ayala Pharmaceuticals AYLA	553 K	-	-	$ 7.46 M	Israel
Corcept Therapeutics Incorporated CORT	2.29 M	$ 82.65	-	$ 8.53 B	USA
Aytu BioScience AYTU	42.1 M	$ 2.45	-3.16 %	$ 15.4 M	USA
ChromaDex Corporation CDXC	5.46 M	-	-0.88 %	$ 598 M	USA
AstraZeneca PLC AZN	30.8 B	$ 92.9	-	$ 96.9 B	Britain
Acorda Therapeutics ACOR	257 M	-	-24.86 %	$ 820 K	USA
Brickell Biotech BBI	146 K	-	-5.38 %	$ 6.06 M	USA
Celldex Therapeutics CLDX	17.3 M	$ 26.4	-	$ 1.7 M	USA